Xilio Therapeutics

NASDAQ: XLO
Engineering tumor-activated therapies for targeted cancer treatment.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Waltham, MA

Initial Investment

2016
Engineering tumor-activated therapies for targeted cancer treatment.

Xilio Therapeutics (NASDAQ: XLO) is a biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor.